Literature DB >> 28259971

Fucoidan modulates cytokine production and migration of THP‑1‑derived macrophages via colony‑stimulating factor‑1.

Peng Li1, Huayang Wang2, Qianqian Shao2, Beihua Kong1, Xun Qu2.   

Abstract

Fucoidan is known for its various biological activities, including immunomodulatory effects on immune cells. However, the effect of fucoidan on the functions of macrophages remains to be elucidated. The present study examined the effects of fucoidan on cytokine production and migration of THP‑1‑derived macrophages and its potential mechanisms. Fucoidan was added during the differentiation process of THP‑1‑derived macrophages along with lipopolysaccharide and interferon‑γ for 42 h, and then macrophages were harvested for functional assays. Fucoidan altered the morphology of THP‑1‑derived macrophages, and also attenuated their migration activity and pro‑inflammatory cytokine production. Additionally, THP‑1‑derived macrophages intensively produced colony‑stimulating factor‑1 (CSF‑1), which was significantly decreased by fucoidan. CSF‑1 neutralizing antibody attenuated the basic production level of pro‑inflammatory cytokines in macrophages. Furthermore, when recombinant human CSF‑1 was added along with fucoidan, the attenuating effects of fucoidan on migration and cytokine production were significantly reversed. In conclusion, the present study suggests that macrophages appear to be a potential target in the immunomodulatory action of fucoidan, and CSF‑1 may be involved in this modulation.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28259971     DOI: 10.3892/mmr.2017.6228

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  4 in total

Review 1.  Application of fucoidan as treatment for cardiovascular and cerebrovascular diseases.

Authors:  Ke Wang; Xueli Xu; Qiang Wei; Qiong Yang; Jiarui Zhao; Yuan Wang; Xia Li; Kai Ji; Shuliang Song
Journal:  Ther Adv Chronic Dis       Date:  2022-04-12       Impact factor: 5.091

2.  Luteolin suppresses the growth of colon cancer cells by inhibiting the IL-6/STAT3 signaling pathway.

Authors:  Jingwen Jiang; Fengting Zhu; Hui Zhang; Tao Sun; Fangfang Fu; Xuewu Chen; Yanhong Zhang
Journal:  J Gastrointest Oncol       Date:  2022-08

3.  The Development of Hyaluronan/Fucoidan-Based Nanoparticles as Macrophages Targeting an Epigallocatechin-3-Gallate Delivery System.

Authors:  Chang-Hsun Ho; Pei-Yi Chu; Shin-Lei Peng; Shun-Chih Huang; Yu-Hsin Lin
Journal:  Int J Mol Sci       Date:  2020-08-31       Impact factor: 5.923

4.  Anti-Inflammatory Activity of Fucoidan Extracts In Vitro.

Authors:  Tauseef Ahmad; Mathew Suji Eapen; Muhammad Ishaq; Ah Young Park; Samuel S Karpiniec; Damien N Stringer; Sukhwinder Singh Sohal; J Helen Fitton; Nuri Guven; Vanni Caruso; Rajaraman Eri
Journal:  Mar Drugs       Date:  2021-12-11       Impact factor: 5.118

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.